Earnings summaries and quarterly performance for GLOBE LIFE.
Executive leadership at GLOBE LIFE.
Frank M. Svoboda
Co-Chairman and Chief Executive Officer
J. Matthew Darden
Co-Chairman and Chief Executive Officer
Christopher K. Tyler
Executive Vice President and Chief Information Officer
Dolores L. Skarjune
Executive Vice President and Chief Administrative Officer
Jennifer A. Haworth
Executive Vice President and Chief Marketing Officer
Michael C. Majors
Executive Vice President, Policy Acquisition and Chief Strategy Officer
R. Brian Mitchell
Executive Vice President, General Counsel and Chief Risk Officer
Rebecca E. Zorn
Executive Vice President and Chief Talent Officer
Robert E. Hensley
Executive Vice President and Chief Investment Officer
Thomas P. Kalmbach
Executive Vice President and Chief Financial Officer
Board of directors at GLOBE LIFE.
Alice S. Cho
Director
Cheryl D. Alston
Director
David A. Rodriguez
Director
James P. Brannen
Director
Linda L. Addison
Lead Independent Director
Marilyn A. Alexander
Director
Mark A. Blinn
Director
Mary E. Thigpen
Director
Matthew J. Adams
Director
Philip M. Jacobs
Director
Research analysts who have asked questions during GLOBE LIFE earnings calls.
Andrew Kligerman
TD Cowen
8 questions for GL
Elyse Greenspan
Wells Fargo
8 questions for GL
John Barnidge
Piper Sandler
8 questions for GL
Suneet Kamath
Jefferies
8 questions for GL
Thomas Gallagher
Evercore
8 questions for GL
Wesley Carmichael
Autonomous Research
8 questions for GL
Ryan Krueger
KBW
7 questions for GL
Jack Matten
BMO Capital Markets
5 questions for GL
Jimmy Bhullar
JPMorgan Chase & Co.
5 questions for GL
Jamminder Bhullar
JPMorgan Chase & Co.
3 questions for GL
Mark Hughes
Truist Securities
3 questions for GL
Wilma Burdis
Raymond James Financial
3 questions for GL
Wilma Jackson Burdis
Raymond James
3 questions for GL
Francis Matten
BMO Capital Markets
2 questions for GL
Joel Hurwitz
Dowling & Partners Securities, LLC
2 questions for GL
Maxwell Fritscher
Truist Financial Corporation
2 questions for GL
Recent press releases and 8-K filings for GL.
- AM Best affirmed the Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Rating of A+ (Excellent) for Globe Life’s life/health subsidiaries, and BBB+ (Good) for Globe Life Inc., all with a stable outlook.
- The affirmations reflect Globe Life’s strong balance sheet, very strong operating performance, favorable business profile, and robust enterprise risk management framework.
- On a statutory basis, year-end 2024 capital and surplus increased, and investment income exceeded $1 billion, driven by improved bond net yields.
- Key debt ratings affirmed include BBB+ on $550 million 4.55% senior unsecured notes due 2028 and $400 million 2.15% notes due 2030, among other senior and subordinated instruments.
- Globe Life delivered $4.73 net income per diluted share (YoY +38%) and $4.81 net operating income per share (YoY +38%) for Q3 2025.
- Life underwriting margin rose 24% to $481.6 M and health underwriting margin increased 25% to $108.4 M in Q3 2025.
- Divisional performance included +5% life premiums at American Income Life & Liberty National, +13% health net sales and +10% health premiums at Family Heritage, and +13% life net sales at Direct to Consumer.
- Repurchased 840,242 shares at a total cost of $113 M, and raised 2025 net operating income per share guidance to $14.40–$14.60 (2026: $14.60–$15.30).
- The U.S. Attorney’s Office for the Western District of Pennsylvania has closed its investigation into Globe Life and American Income Life, with no enforcement action to be taken.
- The probe stemmed from subpoenas concerning sales practices by independent agents selling AIL policies.
- Globe Life, headquartered in McKinney, TX, employs 16,000 insurance agents, 3,600 corporate staff, and has over 17 million policies in force.
- Globe Life posted net operating income of $271 million ($3.27/share), a 10% increase year-over-year, and GAAP net income of $253 million ($3.50/share), with GAAP ROE of 18.8% and ex-AOCI ROE of 14.4% as of June 30.
- Q2 life premium revenue grew 3% to $840 million with a 6% rise in life underwriting margin to $340 million, while health premium revenue rose 8% to $378 million but health underwriting margin declined 2% to $98 million; full-year guidance: life premium +3.5%, life margin 43–45% of premium, health premium +8–9%, health margin 25–27% of premium.
- Distribution remains strong: average total agent count increased 6% sequentially to 17,621 agents, underpinned by robust recruiting and onboarding across exclusive agencies.
- Capital return: repurchased 1.9 million shares for $226 million at an average price of $121.13 and paid $22 million in dividends in Q2, totaling ~$250 million returned; full-year plan includes $600–650 million in buybacks and $80–90 million in dividends; parent liquidity ended Q2 at $105 million, and a $500 million 30-year contingent capital facility was secured.
- Submitted preliminary plan to Bermuda Monetary Authority to launch a reinsurance affiliate by year-end, aiming to cede up to 25% of statutory life reserves over time, with potential to unlock incremental annual cash flow of $200 million by 2027.
- Earnings Performance: Q1 net income reached $255 million with EPS of $3.01 (up from $2.67) and a reported ROE of 19.0%.
- Insurance Operations: Life insurance premiums increased by 3% to $830 million and health premiums by 8% to $370 million, with improved underwriting margins.
- Capital Management: The company repurchased 1.5 million shares for approximately $177 million and returned $197 million to shareholders.
- Guidance Update: Full-year net operating EPS guidance is set between $13.45 and $14.05 per diluted share, supported by favorable remeasurement gains and strategic capital allocation.
Quarterly earnings call transcripts for GLOBE LIFE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track GLOBE LIFE's earnings for you
Get instant analysis when filings drop